SPR免疫竞争法研究小分子吗啡与其抗体间作用的动力学特征

表面等离子体共振技术(SPR)主要应用于生物大分子相互作用的研究,本文采用溶液竞争法,测定了小分子吗啡与其抗体作用的结合常数K₁,并计算了吗啡抗体与吗啡化牛血清白蛋白的结合常数K₂.证明了多抗对抗原的亲和力较单抗大,并表明大分子蛋白质的存在对抗体与待测物的结合有阻碍作用.     

LiCaBO3的合成和LiBO2-CaO二元体系相图

某些无水硼酸盐具有熔点高、耐潮解、损伤阈值高、光学透过波段好等优点,在材料科学领域中一直受到人们的注视。陈创天等首次得到新型紫外倍频材料—低温相偏硼酸钡。之后,又合成了具有倍频效应的晶体材料α-LiCdBO_3。     

手性胶束中的有机反应(Ⅴ)——手性胶束中查耳酮的不对称环氧化

本文报道查耳酮用H₂O₂在手性表面活性剂N,N-二甲基-N-十二烷基麻黄素澳化铵(1a)及N,N-二甲基-N-十六烷基麻黄素溴化铵(1b)形成的手性胶柬水溶液中的不对称环氧化反应,得到相应的手性α,β-环氧酮,对映体过量为5～8%.     

CuCl catalyst heterogenized on diamide immobilized SBA-15 for efficient oxidative carbonylation of methanol to dimethylcarbonate

CuCl has been successfully immobilized on a novel diamide modified SBA-15, and proven to be an efficient heterogenized catalyst for the oxidative carbonylation of methanol to dimethylcarbonate.     

压电胰岛素-C肽微阵列免疫传感器研究

以AT切型、基频10MHz的镀金膜石英晶体作为换能器,将抗人胰岛素和C肽单克隆抗体固定在石英晶体电极表面,用2×5检测池固定夹具构建一种新型压电胰岛素-C肽微阵列免疫传感器.研究了抗体固定方法、抗体工作浓度、固定量、一致性以及传感器的响应参数如检测温度、时间和特异性等的影响.该微阵列传感器在胰岛素浓度为2.5～160.0mIU/L、C肽浓度为0.375～12.0ng/mL范围内响应特性良好,压电晶体频率偏移值与胰岛素和C肽浓度呈良好的线性关系.将此微阵列传感器用于人血清标本的测定,结果与放射免疫法符合(r为0.92和0.94).此微阵列传感器具有灵敏度高、特异性好,低密度阵列结构,检测通量较高,不需标记,操作简单、能实时在线检测和重复使用等优点,能用于临床实验诊断,具有临床推广应用价值.     

SYNTHESIS AND THERMAL PROPERTIES OF POLYBENZOXAZOLE FROM SOLUBLE PRECURSOR WITH HYDROXY-SUBSTITUTED POLYENAMINONITRILE

Aromatic polybenzoxazole (PBO) precursor, hydroxy-substituted polyenaminonitrile, was prepared by direct polycondensation of 1,4-bis(l-chloro-2,2-dicyanovinyl)benzene (CCB) and 4,6-diaminoresorcinol dihydrochloride (DAR) using pyridine and N,N-dimethylacetamide as condensing agent and solvent. The precursor has good solubility in polar aprotic solvent which is due to the strong dipolar nature of the main chain. The soluble precursor was subjected to thermal cyclization in an inert atmosphere to convert it into the corresponding PBO, which has its 5% weight loss temperature at 540℃ The fully cyclized PBO were characterized by FT-IR and TGA. The introduction of 10% mol 1,3,5-benzenetricarboxylic chloride (BTC) into the main chain not only has little effect on the solubility of PBO precursor but also raises its 5% weight loss temperature to 552℃ and char yield at 700℃ for the cyclized PBO with BTC.     

2-羟基-萘甲醛缩对甲氧基苯甲酰腙的合成与荧光性质研究

合成了2-羟基-萘甲醛缩对甲氧基苯甲酰腙,采用元素分析和红外光谱对该化合物结构进行了表征。详细研究了该化合物在固态、不同溶剂中和有锌离子存在下的荧光光谱,探讨了溶剂极性和锌离子的存在对其荧光光谱的影响。结果表明：该化合物的固体和溶液都有很强的荧光,溶剂对其荧光性质有较大的影响,其DMF溶液在485nm处发光最强。金属锌离子具有荧光增敏性。     

高效液相色谱-质谱法分析测定水中氨基甲酸酯

采用固相萃取-高效液相色谱-质谱法（LC／MS）检测研究了水中氨基甲酸酯农药残留。水样用固相萃取富集净化,环己烷＋乙酸乙酯（1＋1）洗脱;以甲醇-10mmol／L乙酸铵为梯度流动相,Symmetry C18柱高效液相色谱分离。电喷雾正离子模式,选择质子化氨基甲酸酯分子离子[M＋H]^＋为定量离子进行MS测定。结果表明,6种氨基甲酸酯组分的平均加标回收率为73．5％～89．8％;相对标准偏差为4．50％～12．6％;水样浓缩至1／2500后的检出限为0．8～3．2ng／L。本法具有非常高的选择性、灵敏度和准确度,完全能满足水中痕量氨基甲酸酯农残的高灵敏分析。     

载体模板效应对氧化钯的热化学行为及其甲烷燃烧稳定性的影响

通过对PdO活性组分在单斜与四方型氧化锆载体上的热化学性质和催化活性进行比较性的研究显示, 单斜型ZrO₂的表面原子能够满足与PdO的结构适应性匹配条件, 它可以通过界面原子的取向附生作用对表面PdO物种聚集形态进行调控, 从而促进PdO组分在单位载体表面上的分散. 此外, 升降温循环过程的DTG分析还表明, 单斜载体模板在反复的氧化还原循环中逐渐将结晶型PdO加工成取向附生型PdO, 不断改善PdO物种的氧迁移性质, 促进了热还原钯物种在高温区的氧化再生. 这两种载体效应有效地抑制了甲烷燃烧反应在高温区的活性振荡, 增加了燃烧的稳定性与催化剂的反应耐受性. 四方ZrO₂晶相在载体内的掺杂将导致上述的载体效应受到明显抑制.     

Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase

The SARS coronavirus 3C-like proteinase is considered as a potential drug design target for the treatment of severe acute respiratory syndrome (SARS). Owing to the lack of available drugs for the treatment of SARS, the discovery of inhibitors for SARS coronavirus 3C-like proteinase that can potentially be optimized as drugs appears to be highly desirable. We have built a "flexible" three-dimensional model for SARS 3C-like proteinase by homology modeling and multicanonical molecular dynamics method and used the model for virtual screening of chemical databases. After Dock procedures, strategies including pharmocophore model, consensus scoring, and "drug-like" filters were applied in order to accelerate the process and improve the success rate of virtual docking screening hit lists. Forty compounds were purchased and tested by HPLC and colorimetric assay against SARS 3C-like proteinase. Three of them including calmidazolium, a well-known antagonist of calmodulin, were found to inhibit the enzyme with an apparent K(i) from 61 to 178 microM. These active compounds and their binding modes provide useful information for understanding the binding sites and for further selective drug design against SARS and other coronavirus.